SCHEMBL21395066

SCHEMBL21395066

O=C(Nc1ccc(Cc2cccc(Cl)c2)cn1)c1ccc(C(F)F)nc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
F10 P00742 6/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CXCR2 P25025 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
P4HTM Q9NXG6 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
GCK P35557 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21394657 0.90 ALDH1A1 (0.49) ALDH1A1F10SMN1; SMN2NPC1PKM
SCHEMBL21394651 0.90 ALDH1A1 (0.49) ALDH1A1F10SMN1; SMN2NPC1PKM
SCHEMBL21394722 0.88 ALDH1A1 (0.45) ALDH1A1F10SMN1; SMN2NPC1PKM
SCHEMBL29357095 0.84 F10 (0.53) ALDH1A1F10SMN1; SMN2NPC1PKM
SCHEMBL21394880 0.84 F10 (0.53) ALDH1A1F10SMN1; SMN2NPC1PKM
SCHEMBL21394466 0.83 ALDH1A1 (0.48) ALDH1A1F10SMN1; SMN2NPC1PKM
SCHEMBL21395090 0.83 ALDH1A1 (0.51) ALDH1A1F10SMN1; SMN2TSHRRAB9A
SCHEMBL29356935 0.83 ALDH1A1 (0.48) ALDH1A1F10SMN1; SMN2NPC1PKM
SCHEMBL22479547 0.82 ALDH1A1 (0.50) ALDH1A1F10SMN1; SMN2MEN1KMT2A
SCHEMBL21394834 0.82 SIRT2 (0.47) ALDH1A1F10SMN1; SMN2NPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019183587-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed